The vagus nerve is the principal brake on heart rate. Its cardiac branches release acetylcholine onto the sinoatrial (SA) node and the atrioventricular (AV) node, activating muscarinic M2 receptors that open inward-rectifier potassium channels (IKACh). The resulting outward potassium current hyperpolarises the pacemaker cells, slowing spontaneous depolarisation and reducing the rate at which the SA node fires. When this parasympathetic brake is strong enough to hold resting heart rate below 60 beats per minute, the result is bradycardia — and the vagus nerve is its most common physiological cause.
How the Vagus Nerve Slows the Heart
The right vagus nerve preferentially innervates the SA node, while the left vagus nerve has a stronger influence on the AV node, though there is considerable overlap. Acetylcholine released at these sites acts within one to two heartbeats — far faster than sympathetic activation, which takes several seconds to accelerate the heart. This speed difference is why a sudden fright can cause an almost instantaneous drop in heart rate (the vagal response is already active) before the sympathetic surge kicks in to raise it.
The intensity of this vagal braking is called vagal tone. At rest, the vagus nerve is continuously active, holding heart rate well below the SA node’s intrinsic firing rate of roughly 100 bpm. This is why a resting heart rate of 60–80 bpm is normal — it reflects tonic vagal restraint, not the heart’s natural speed. Withdraw that vagal input (with atropine, for example, which blocks muscarinic receptors) and resting heart rate jumps to around 100 bpm.
Physiological Bradycardia: Athletes and High Vagal Tone
Not all bradycardia is pathological. Endurance athletes commonly have resting heart rates in the 40s or even high 30s. This athletic bradycardia was long attributed entirely to increased vagal tone from training. The picture is now more nuanced: a 2014 study by D’Souza and colleagues in Circulation: Arrhythmia and Electrophysiology showed that exercise-trained mice developed intrinsic SA node remodelling — downregulation of the HCN4 “funny current” channel — independent of autonomic input. In humans, both mechanisms likely contribute: enhanced vagal tone plus structural adaptation of the SA node itself.
For most fit individuals, this bradycardia is entirely benign. It becomes a clinical concern only when accompanied by symptoms — dizziness, fatigue, exercise intolerance, or syncope — indicating that the heart rate is too slow to maintain adequate cardiac output.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,684 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- HRV biofeedback
- Polyvagal-informed therapy
- Somatic therapy
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
Vasovagal Syncope: When the Brake Hits Too Hard
Vasovagal syncope (the common faint) is the most dramatic example of vagally mediated bradycardia. The Bezold-Jarisch reflex is thought to drive many episodes: vigorous contraction of an under-filled ventricle activates cardiac mechanoreceptors, triggering an abrupt vagal surge that drops heart rate and blood pressure simultaneously. The result is cerebral hypoperfusion and loss of consciousness.
Triggers include prolonged standing, heat exposure, dehydration, pain, blood draws, and strong emotional responses. The bradycardia in vasovagal syncope is typically transient — heart rate recovers within seconds to minutes once the person is supine and the reflex arc resets. Tilt-table testing can reproduce the response under controlled conditions to confirm the diagnosis.
Pathological Causes of Vagal Bradycardia
Beyond physiological high vagal tone and vasovagal reflexes, several conditions produce pathological bradycardia through vagal or parasympathetic mechanisms:
Sick sinus syndrome. Degenerative disease of the SA node, often age-related, impairs its ability to generate impulses. While this is an intrinsic conduction problem rather than purely vagal, heightened vagal tone in these patients can push an already compromised SA node into clinically significant bradycardia or sinus pauses.
Carotid sinus hypersensitivity. In some older adults, pressure on the carotid sinus (from a tight collar, head turning, or shaving) triggers an exaggerated vagal response, producing bradycardia or asystole lasting several seconds. This is diagnosed with carotid sinus massage under monitored conditions.
Increased intracranial pressure. The Cushing reflex — bradycardia with hypertension and irregular breathing — occurs when rising intracranial pressure compresses the brainstem, activating vagal nuclei. This is a neurosurgical emergency, not a benign vagal phenomenon.
Medications. Beta-blockers, calcium channel blockers (verapamil, diltiazem), digoxin, and cholinesterase inhibitors all enhance vagal effects on the heart or mimic them, and dose-dependent bradycardia is a common side effect.
VNS-Induced Bradycardia
Vagus nerve stimulation (VNS) devices, implanted to treat drug-resistant epilepsy or depression, deliver programmed electrical pulses to the left cervical vagus nerve. Bradycardia during VNS is uncommon (reported in roughly 0.1% of implantations) because the left vagus preferentially targets the AV node rather than the SA node, and stimulation parameters are calibrated to avoid cardiac effects. However, rare cases of significant intraoperative bradycardia or asystole during lead testing have been documented. Current guidelines recommend cardiac monitoring during initial device activation.
Diagnosis and Management
Diagnosing vagally mediated bradycardia requires distinguishing it from intrinsic conduction disease. A 12-lead ECG identifies the rhythm (sinus bradycardia, junctional rhythm, or heart block). Holter monitoring over 24–72 hours captures intermittent episodes. Tilt-table testing assesses vasovagal susceptibility. Electrophysiology studies are reserved for cases where the mechanism remains unclear.
Management depends on the cause. Physiological bradycardia in asymptomatic athletes requires no treatment. Vasovagal syncope is managed with counterpressure manoeuvres, adequate hydration, and avoidance of triggers; in refractory cases, midodrine or fludrocortisone may help. Drug-induced bradycardia resolves with dose adjustment or discontinuation. For symptomatic bradycardia from sick sinus syndrome, AV block, or carotid sinus hypersensitivity that does not respond to conservative measures, a permanent pacemaker is the definitive treatment.
The vagus nerve’s role as the heart’s pacemaker brake is just one part of its body-wide influence. Get the Vagus Nerve & Me eBook for a clear guide to what this nerve does and how to work with it.




